A
$ Value
$0
Shares
12,050
Price
$0
Filed
Feb 24
Insider
Name
Freedland Cory S.
Title
—
CIK
0001832569
Roles
Director
Transaction Details
Transaction Date
2026-02-20
Code
A
Table
Derivative
Ownership
Direct
Equity Swap
No
Shares After
12,050
Footnotes
The option vests as to 1/12 of the total shares monthly beginning March 20, 2026 until the option is fully vested on February 20, 2027, subject to the Reporting Person's provision of service to the Issuer on each vesting date.
Filing Info
Other Insiders at NGNE (90d)
| Insider | Bought | Sold | Last |
|---|---|---|---|
| BAFFI ROBERT | — | — | 2026-02-20 |
| PALEKAR ROHAN | — | — | 2026-02-20 |
|
Cvijic Christine Mikail
President and CFO
|
— | $260K | 2026-03-26 |
|
McMinn Rachel
Chief Executive Officer
|
— | $74K | 2026-03-26 |
| Noonberg Sarah B. | — | — | 2026-02-20 |
|
Jordan Julie
Chief Medical Officer
|
— | $18K | 2026-03-26 |
|
Cobb Stuart
Chief Scientific Officer
|
— | $141K | 2026-03-13 |
| Woods Keith | — | — | 2026-02-20 |